Healthcare
Live Price
Offline$107.58
-0.82% today
1Y Change
+46.54%
Window
Jun 25, 2025 → Jun 17, 2026
Coverage: 246 bars · Jun 25, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Incyte Corporation (INCY) is a Healthcare stock with a market cap of $19.03B and listed on NASDAQ. The stock last traded around $107.58 and up 46.5% across the available one-year price window (Jun 25, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +21.2%, EPS growth of +4018.8%, a dividend yield of 0.0%. What stands out right now is revenue +21.2%, EPS +4018.8%, free cash flow +443.9% with operating margin 26.8% and ROIC 20.0%. Valuation is more restrained than many high-expectation growth names at P/E 13.3 and price/sales 3.6. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines INCY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
INCY
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
INCY Max Drawdown
-18.33%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for INCY and SPY.
Unable to load analyst forecasts.
Timed out loading forecasts for INCY
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.